Position in DERM
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$84,542
+$16,767 QoQ
Shares Held
11,941
-17.4% QoQ
Ownership
0.042%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#51
of 71 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DERM Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Atria Investments, Inc holds $17,433,997 across 16 Drug Manufacturers - Specialty & Generic names. DERM ranks #15 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
41,255 | $2,964,584 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
107,060 | $2,634,746 | |
| 3 | VTRS |
Viatris Inc
|
162,893 | $2,586,740 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
12,667 | $2,134,896 | |
| 5 | HLN |
Haleon plc
|
178,931 | $1,669,426 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
39,602 | $1,341,715 | |
| 7 | PBH |
Prestige Consumer Healthcare Inc.
|
17,098 | $808,222 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
42,964 | $688,712 |
All Filings in DERM
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $84,542 | 11,941 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $67,775 | 14,451 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $100,823 | 13,077 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $182,485 | 25,630 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $266,988 | 37,185 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $263,488 | 44,659 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $169,869 | 43,445 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $250,843 | 44,397 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $312,100 | 55,337 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||